- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03427996
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice (IRIS-ROTA)
December 22, 2023 updated by: Seung-Jung Park
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
This study evaluates the effectiveness and safety rotational atherectomy in routine clinical practice.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jung-hee Ham, RN
- Phone Number: 82230104728
- Email: cvcrc5@amc.seoul.kr
Study Contact Backup
- Name: Seung-jung Park, MD
- Email: sjpark@amc.seoul.kr
Study Locations
-
-
-
Bucheon, Korea, Republic of
- Recruiting
- Soon Chun Hyang University Hospital Bucheon
-
Contact:
- Nae-Hee Lee, MD
-
Principal Investigator:
- Nae-Hee Lee, MD
-
Daegu, Korea, Republic of
- Recruiting
- Daegu Catholic University Medical Center
-
Contact:
- Kee-Sik Kim, MD
-
Principal Investigator:
- Kee-Sik Kim, MD
-
Daejeon, Korea, Republic of
- Terminated
- Chungnam National University Hospital
-
Daejeon, Korea, Republic of
- Withdrawn
- The Catholic University of Korea, Daejeon St. Mary's Hospital
-
Gwangju, Korea, Republic of
- Not yet recruiting
- Chonnam National University Hospital
-
Contact:
- Young-jun Hong, MD
-
Principal Investigator:
- Young-jun Hong, MD
-
Pusan, Korea, Republic of
- Active, not recruiting
- Inje University Pusan Paik Hospital
-
Seongnam, Korea, Republic of
- Terminated
- Bundang CHA Hospital
-
Seoul, Korea, Republic of
- Recruiting
- Asan Medical Center
-
Contact:
- Seung-jung Park, MD
-
Principal Investigator:
- Seung-jung Park, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Consecutive percutaneous coronary intervention patients receiving rotational atherectomy
Description
Inclusion Criteria:
- Patients ≥ 19 years old
- Patients who received rotational atherectomy
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria:
- Life expectancy <1y
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Coronary disease
|
Percutaneous coronary intervention with rotational atherectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Target vessel failure (TVF)
Time Frame: 1 year
|
Target vessel failure (TVF) composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target Vessel Revascularization (TVR) at 12 months after the procedure.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All death
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Cardiac death
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Myocardial infarction
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Composite of death or myocardial infarction
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Composite of cardiac death or myocardial infarction
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Target-lesion revascularization (TLR)
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Target-vessel revascularization (TVR)
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Stent thrombosis
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
according to Academic Research Consortium (ARC) criteria
|
1-,6-, and 12-months, and 3-,5-years
|
Stroke
Time Frame: 1-,6-, and 12-months, and 3-,5-years
|
1-,6-, and 12-months, and 3-,5-years
|
|
Procedural success
Time Frame: 7 days
|
Post-procedural diameter stenosis < 30% without death, Q-wave myocardial infarction, or urgent revascularization during the index admission
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 4, 2018
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
February 5, 2018
First Submitted That Met QC Criteria
February 5, 2018
First Posted (Actual)
February 9, 2018
Study Record Updates
Last Update Posted (Actual)
December 26, 2023
Last Update Submitted That Met QC Criteria
December 22, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMCCV2018-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Stenosis
-
Biotronik (Beijing) Medical Device Ltd.Biotronik AGEnrolling by invitationNative Coronary Artery Stenosis | In-Stent Stenosis (Restenosis) of Coronary Artery StentChina
-
Axetis AGUnknownNative Coronary Artery StenosisNetherlands
-
Fundación Pública Andaluza Progreso y SaludUnknownUnprotected Left Main Coronary Artery StenosisSpain
-
ECRI bvBoston Scientific Corporation; Philips HealthcareActive, not recruitingLeft Main Coronary Artery StenosisSpain, United Kingdom, Italy
-
Institut Mutualiste MontsourisCompletedLeft Main Coronary Artery StenosisFrance
-
Columbia UniversityRecruitingLeft Anterior Descending Coronary Artery StenosisUnited States
-
Tryton Medical, Inc.UnknownLeft Main Coronary Artery StenosisGermany
-
Das Radiologische ZentrumHeidelberg UniversityRecruiting
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy
-
Concept Medical Inc.Cardiovascular Research Foundation, New YorkNot yet recruitingCardiovascular Diseases | Coronary Artery Disease | Native Coronary Artery Stenosis
Clinical Trials on Rotational atherectomy
-
National Heart Centre SingaporeBoston Scientific CorporationRecruitingCoronary Artery CalcificationSingapore, Japan
-
Xijing HospitalCompletedCoronary Artery DiseaseChina
-
Segeberger Kliniken GmbHCompleted
-
University Hospital, ToulouseCompletedAngioplastySpain, Russian Federation, Italy, France, Austria, Germany, Greece, Poland
-
SS Annunziata Hospital, SaviglianoNot yet recruitingMyocardial Infarction | Coronary Artery Disease
-
Beijing Anzhen HospitalBSC International Medical Trading (Shanghai) Co., Ltd.Completed
-
Rex MedicalSyntactxCompletedPeripheral Artery DiseaseUnited States
-
Samsung Medical CenterUnknownCoronary Artery DiseaseKorea, Republic of
-
Columbia UniversityCompletedCoronary Artery Disease (CAD)United States
-
Segeberger Kliniken GmbHRecruitingCoronary Artery DiseaseGermany